154 related articles for article (PubMed ID: 30771899)
1. Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.
Kaowinn S; Yawut N; Koh SS; Chung YH
Biochem Biophys Res Commun; 2019 Mar; 511(1):122-128. PubMed ID: 30771899
[TBL] [Abstract][Full Text] [Related]
2. Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling.
Kaowinn S; Kim J; Lee J; Shin DH; Kang CD; Kim DK; Lee S; Kang MK; Koh SS; Kim SJ; Chung YH
Oncotarget; 2017 Jan; 8(3):5092-5110. PubMed ID: 27974707
[TBL] [Abstract][Full Text] [Related]
3. STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
Kaowinn S; Kaewpiboon C; Koh SS; Krämer OH; Chung YH
Oncol Rep; 2018 Nov; 40(5):2619-2627. PubMed ID: 30226605
[TBL] [Abstract][Full Text] [Related]
4. Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis.
Kaowinn S; Seo EJ; Heo W; Bae JH; Park EJ; Lee S; Kim YJ; Koh SS; Jang IH; Shin DH; Chung YH
Biochem Biophys Res Commun; 2019 Jul; 514(4):1278-1284. PubMed ID: 31113615
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling.
Yawut N; Kaewpiboon C; Budluang P; Cho IR; Kaowinn S; Koh SS; Chung YH
Cancer Manag Res; 2020; 12():10243-10250. PubMed ID: 33116878
[TBL] [Abstract][Full Text] [Related]
6. N-Benzyl-N-methyl-dodecan-1-amine, a novel compound from garlic, exerts anti-cancer effects on human A549 lung cancer cells overexpressing cancer upregulated gene (CUG)2.
Kaowinn S; Kaewpiboon C; Kim JE; Lee MR; Hwang DY; Choi YW; Kim HW; Park JK; Song KM; Lee NH; Maeng JS; Chung YH
Eur J Pharmacol; 2018 Dec; 841():19-27. PubMed ID: 30287155
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
8. Translocalization of enhanced PKM2 protein into the nucleus induced by cancer upregulated gene 2 confers cancer stem cell-like phenotypes.
Yawut N; Kaowinn S; Cho IR; Budluang P; Kim S; Kim S; Youn SE; Koh SS; Chung YH
BMB Rep; 2022 Feb; 55(2):98-103. PubMed ID: 35000669
[TBL] [Abstract][Full Text] [Related]
9. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling.
Kaowinn S; Jun SW; Kim CS; Shin DM; Hwang YH; Kim K; Shin B; Kaewpiboon C; Jeong HH; Koh SS; Krämer OH; Johnston RN; Chung YH
Cell Oncol (Dordr); 2017 Dec; 40(6):549-561. PubMed ID: 28776259
[TBL] [Abstract][Full Text] [Related]
10. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.
Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH
Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157
[TBL] [Abstract][Full Text] [Related]
11. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
13. Autophagy links β-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase.
Pang M; Wang H; Rao P; Zhao Y; Xie J; Cao Q; Wang Y; Wang YM; Lee VW; Alexander SI; Harris DC; Zheng G
Int J Biochem Cell Biol; 2016 Jul; 76():123-34. PubMed ID: 27177845
[TBL] [Abstract][Full Text] [Related]
14. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
16. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
17. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
18. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells.
Kong HJ; Kwon EJ; Kwon OS; Lee H; Choi JY; Kim YJ; Kim W; Cha HJ
Int J Oncol; 2021 Jan; 58(1):111-121. PubMed ID: 33367928
[TBL] [Abstract][Full Text] [Related]
20. Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation.
Malilas W; Koh SS; Kim S; Srisuttee R; Cho IR; Moon J; Yoo HS; Oh S; Johnston RN; Chung YH
Int J Oncol; 2013 Oct; 43(4):1111-6. PubMed ID: 23917355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
